Gladstone Institutional Advisory’s Astera Labs ALAB Stock Holding History

Gladstone Institutional Advisory’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$280K	Buy	+579	New	+$154K	0.01%	759

Other funds holding ALAB

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

VWS

Virtus Wealth Solutions Cranford, New Jersey $735M AUM 209.29% 1-Year Est. Return

SSA

Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

PAS

Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

TEC

Tensor Edge Capital Weston, Massachusetts $1.51B AUM

Gladstone Institutional Advisory's ALAB Position: Q2 2026 in Review

Gladstone Institutional Advisory opened a new position in Astera Labs (ALAB) in Q2 2026: 579 shares worth $280K. The stake represents 0.01% of the portfolio and ranks #759 among its holdings.

270 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Gladstone Institutional Advisory held 579 shares of Astera Labs worth $280K as of Q2 2026.
Astera Labs was a new Gladstone Institutional Advisory position in Q2 2026.
Astera Labs made up 0.01% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #759 holding.
270 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.